Silverarc Capital Management, LLC Portfolio Holdings

Silverarc Capital Management, LLC

  • $486 Million
  • Q3 2025

Silverarc Capital Management, LLC has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $486 Million distributed in 82 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rhythm Pharmaceuticals, Inc. with a value of $37.4M, Avidity Biosciences, Inc. with a value of $36.8M, Nuvalent, Inc. with a value of $32.2M, Uro Gen Pharma Ltd. with a value of $30.8M, and Akero Therapeutics, Inc. with a value of $30.6M.

Examining the 13F form we can see an increase of $72.1M in the current position value, from $414M to 486M.

Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $486 Million
Healthcare: $486 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.54B
$37.4 Million 7.69% of portfolio
369,996
Q3 2025 Reduced 7.68%
$3.69B
$36.8 Million 7.58% of portfolio
844,633
Q3 2025 Added 106.01%
$4.15B
$32.2 Million 6.63% of portfolio
372,300
Q3 2025 Added 58.03%
$553M
$30.8 Million 6.34% of portfolio
1,577,283
Q3 2025 Reduced 22.01%
$2.52B
$30.6 Million 6.29% of portfolio
643,636
Q3 2025 Reduced 9.83%
$26.2B
$29.8 Million 6.13% of portfolio
206,648
Q3 2025 Reduced 17.03%
$1.4B
$26.6 Million 5.47% of portfolio
455,000
Q3 2025 Added 124.62%
$518M
$23.2 Million 4.79% of portfolio
1,948,808
Q3 2025 Added 8.22%
$328M
$16.5 Million 3.39% of portfolio
1,363,378
Q3 2025 Reduced 25.59%
$1.02B
$16.4 Million 3.37% of portfolio
1,000,000
Q3 2025 Added 149.04%
$255M
$12.6 Million 2.59% of portfolio
4,779,082
Q3 2025 Reduced 7.14%
$2.21B
$11.7 Million 2.41% of portfolio
815,075
Q3 2025 New
$6.25B
$11.6 Million 2.39% of portfolio
211,000
Q3 2025 New
$2.87B
$11.3 Million 2.33% of portfolio
314,339
Q3 2025 Added 9.22%
$24.1B
$11.3 Million 2.32% of portfolio
80,419
Q3 2025 New
$11.4B
$10.6 Million 2.19% of portfolio
53,554
Q3 2025 Reduced 38.13%
$743M
$9.51 Million 1.96% of portfolio
700,000
Q3 2025 New
$1.2B
$9.03 Million 1.86% of portfolio
348,922
Q3 2025 Added 75.83%
$351M
$9.01 Million 1.85% of portfolio
933,541
Q3 2025 New
$1.95B
$8.74 Million 1.8% of portfolio
233,920
Q3 2025 Reduced 31.4%
$2.82B
$8.09 Million 1.67% of portfolio
235,791
Q3 2025 Reduced 47.43%
$940M
$7.14 Million 1.47% of portfolio
463,708
Q3 2025 Added 15.07%
$1.15B
$5.58 Million 1.15% of portfolio
259,509
Q3 2025 New
$4.77B
$5.42 Million 1.11% of portfolio
180,513
Q3 2025 New
$661M
$5.26 Million 1.08% of portfolio
588,789
Q3 2025 Added 9.12%
$26.5M
$5.25 Million 1.08% of portfolio
994,754
Q3 2025 Added 8.37%
$671M
$5.15 Million 1.06% of portfolio
694,942
Q3 2025 New
$146M
$4.77 Million 0.98% of portfolio
3,311,165
Q3 2025 Added 9.14%
$795M
$4.59 Million 0.94% of portfolio
183,903
Q3 2025 New
$1.38B
$4.36 Million 0.9% of portfolio
88,686
Q3 2025 New
$287M
$4.32 Million 0.89% of portfolio
2,715,786
Q3 2025 Added 9.14%
$121M
$4.21 Million 0.87% of portfolio
1,897,383
Q3 2025 New
$13.5M
$4.13 Million 0.85% of portfolio
2,850,987
Q3 2025 Added 3.23%
$18.8M
$4.09 Million 0.84% of portfolio
2,782,923
Q3 2025 Added 0.11%
$2.6B
$3.43 Million 0.71% of portfolio
141,238
Q3 2025 Added 2,724.76%
$404M
$3.19 Million 0.66% of portfolio
230,837
Q3 2025 New
$315M
$2.98 Million 0.61% of portfolio
1,368,075
Q3 2025 Reduced 46.76%
$76.8M
$2.19 Million 0.45% of portfolio
203,386
Q3 2025 Added 97.41%
$2.34B
$2.08 Million 0.43% of portfolio
50,000
Q3 2025 New
$3.55B
$1.38 Million 0.28% of portfolio
50,000
Q3 2025 New
$975M
$1.27 Million 0.26% of portfolio
100,000
Q3 2025 New
$5.78M
$454,000 0.09% of portfolio
639,531
Q3 2025 Reduced 9.97%
$472M
$215,000 0.04% of portfolio
30,000
Q3 2025 Reduced 63.42%
$193M
$63,000 0.01% of portfolio
3,445
Q3 2025 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Sionna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 41.51%
Fractyl Health Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 5,132.24%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 112.52%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 6.75%

Summary

  • Portfolio
  • No. of Stocks 82
  • Current Value $486 Million
  • Prior Value $414 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 30 stocks
  • Additional Purchases 27 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email